These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38906154)

  • 1. How can we integrate the biology of breast cancer cell dormancy into clinical practice?
    Elkholi IE; Rose AAN; Aguirre-Ghiso JA; Côté JF
    Cancer Cell; 2024 Jul; 42(7):1147-1151. PubMed ID: 38906154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding NR2F1-AS1 is associated with tumor recurrence in estrogen receptor-positive breast cancers.
    Sanchez Calle A; Yamamoto T; Kawamura Y; Hironaka-Mitsuhashi A; Ono M; Tsuda H; Shimomura A; Tamura K; Takeshita F; Ochiya T; Yamamoto Y
    Mol Oncol; 2020 Sep; 14(9):2271-2287. PubMed ID: 32392629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A quantitative insight into metastatic relapse of breast cancer.
    Hanin L; Pavlova L
    J Theor Biol; 2016 Apr; 394():172-181. PubMed ID: 26801873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inter-tumor genomic heterogeneity of breast cancers: comprehensive genomic profile of primary early breast cancers and relapses.
    Fumagalli C; Ranghiero A; Gandini S; Corso F; Taormina S; De Camilli E; Rappa A; Vacirca D; Viale G; Guerini-Rocco E; Barberis M
    Breast Cancer Res; 2020 Oct; 22(1):107. PubMed ID: 33059724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms governing metastatic dormancy in breast cancer.
    Dittmer J
    Semin Cancer Biol; 2017 Jun; 44():72-82. PubMed ID: 28344165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted next-generation sequencing assays using triplet samples of normal breast tissue, primary breast cancer, and recurrent/metastatic lesions.
    Akahane T; Kanomata N; Harada O; Yamashita T; Kurebayashi J; Tanimoto A; Moriya T
    BMC Cancer; 2020 Oct; 20(1):944. PubMed ID: 33004031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bmi-1, c-myc, and Snail expression in primary breast cancers and their metastases--elevated Bmi-1 expression in late breast cancer relapses.
    Joensuu K; Hagström J; Leidenius M; Haglund C; Andersson LC; Sariola H; Heikkilä P
    Virchows Arch; 2011 Jul; 459(1):31-9. PubMed ID: 21638011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to Predict Metastasis in Luminal Breast Cancer? Current Solutions and Future Prospects.
    Tabor S; Szostakowska-Rodzos M; Fabisiewicz A; Grzybowska EA
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer.
    Papadaki C; Stratigos M; Markakis G; Spiliotaki M; Mastrostamatis G; Nikolaou C; Mavroudis D; Agelaki S
    Breast Cancer Res; 2018 Jul; 20(1):72. PubMed ID: 29996899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular dormancy in minimal residual disease following targeted therapy.
    Ruth JR; Pant DK; Pan TC; Seidel HE; Baksh SC; Keister BA; Singh R; Sterner CJ; Bakewell SJ; Moody SE; Belka GK; Chodosh LA
    Breast Cancer Res; 2021 Jun; 23(1):63. PubMed ID: 34088357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Tumor Cells in Early and Advanced Breast Cancer; Biology and Prognostic Value.
    Fabisiewicz A; Szostakowska-Rodzos M; Zaczek AJ; Grzybowska EA
    Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32121386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disseminated cancer cells in breast cancer: Mechanism of dissemination and dormancy and emerging insights on therapeutic opportunities.
    Ramamoorthi G; Kodumudi K; Gallen C; Zachariah NN; Basu A; Albert G; Beyer A; Snyder C; Wiener D; Costa RLB; Czerniecki BJ
    Semin Cancer Biol; 2022 Jan; 78():78-89. PubMed ID: 33626407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast Cancer Metastatic Dormancy and Relapse: An Enigma of Microenvironment(s).
    Elkholi IE; Lalonde A; Park M; Côté JF
    Cancer Res; 2022 Dec; 82(24):4497-4510. PubMed ID: 36214624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dormancy in Breast Cancer.
    Dalla E; Sreekumar A; Aguirre-Ghiso JA; Chodosh LA
    Cold Spring Harb Perspect Med; 2023 Nov; 13(11):. PubMed ID: 37037598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time to metastatic relapse and breast cancer cells dissemination in bone marrow at metastatic relapse.
    Bidard FC; Vincent-Salomon A; Sigal-Zafrani B; Rodrigues M; Diéras V; Mignot L; Sastre-Garau X; Poupon MF; Pierga JY
    Clin Exp Metastasis; 2008; 25(8):871-5. PubMed ID: 18989740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploiting Mouse Models to Recapitulate Clinical Tumor Dormancy and Recurrence in Breast Cancer.
    Gu Y; Bui T; Muller WJ
    Endocrinology; 2022 Jun; 163(6):. PubMed ID: 35560214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor dormancy: elevated expression of stanniocalcins in late relapsing breast cancer.
    Joensuu K; Heikkilä P; Andersson LC
    Cancer Lett; 2008 Jun; 265(1):76-83. PubMed ID: 18355956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPFIA1 is upregulated in liver metastasis of breast cancer and is a potential poor prognostic indicator of metastatic relapse.
    Yang J; Wu NN; Huang DJ; Luo YC; Huang JZ; He HY; Lu HL; Song WL
    Tumour Biol; 2017 Jul; 39(7):1010428317713492. PubMed ID: 28720060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Claudin-2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrences.
    Kimbung S; Kovács A; Bendahl PO; Malmström P; Fernö M; Hatschek T; Hedenfalk I
    Mol Oncol; 2014 Feb; 8(1):119-28. PubMed ID: 24287398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disseminated Tumor Cells and Dormancy in Breast Cancer Progression.
    Banys-Paluchowski M; Reinhardt F; Fehm T
    Adv Exp Med Biol; 2020; 1220():35-43. PubMed ID: 32304078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.